0001209191-17-003700.txt : 20170113
0001209191-17-003700.hdr.sgml : 20170113
20170113170115
ACCESSION NUMBER: 0001209191-17-003700
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170112
FILED AS OF DATE: 20170113
DATE AS OF CHANGE: 20170113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MATEON THERAPEUTICS INC
CENTRAL INDEX KEY: 0000908259
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 133679168
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 GATEWAY BLVD.
STREET 2: SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-635-7000
MAIL ADDRESS:
STREET 1: 701 GATEWAY BLVD.
STREET 2: SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: OXIGENE INC
DATE OF NAME CHANGE: 19930628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHAPLIN DAVID
CENTRAL INDEX KEY: 0001167232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21990
FILM NUMBER: 17528490
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-12
0
0000908259
MATEON THERAPEUTICS INC
MATN
0001167232
CHAPLIN DAVID
C/O MATEON THERAPEUTICS, INC.
701 GATEWAY BLVD, SUITE 210
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Chief Scientific Officer
Employee Stock Option (Right to Buy)
0.375
2017-01-12
4
A
0
262500
0.375
A
2027-01-12
Common Stock
262500
262500
D
Dr. Chaplin was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per share, pursuant to the Mateon Therapeutics, Inc. 2017 Equity Incentive Plan in connection with his service as Chief Scientific Officer.
The Options will vest in forty-eight equal monthly installments beginning one month after the grant date.
/s/ Megan N. Gates, attorney-in-fact
2017-01-13